Impact Proteomics

Impact Proteomics is a biotech startup founded in 2017, based in the United States, specializing in immune profiling for antigen discovery and proteomics & multiomics sample prep. The company provides a unique and unbiased platform for known and novel antigen discovery, catering to scientists in academia and industry. This data-driven approach aims to facilitate the development of new therapeutics and advance the diagnosis, prognosis, and treatment of diseases like autoimmune and cancer. Alongside its proprietary discovery platform, Impact Proteomics offers proteomic and multiomic sample preparation products and services. As of now, there is no public information available about the startup's recent investment activities or investors. The company operates within the Biotechnology and Nutrition industries.